Revenue Disaggregated Revenue by Product Line (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)
Disaggregation of Revenue [Line Items]
Revenues	$ 589,131	$ 553,311	$ 1,752,241	$ 1,671,270
% Revenue to Medline	0.18	0.18	0.17	0.16
Infusion Consumables [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 264,875	$ 242,010	$ 770,730	$ 715,108
Infusion Systems [Member]
Disaggregation of Revenue [Line Items]
Revenues	159,769	148,981	480,745	463,836
Vital Care
Disaggregation of Revenue [Line Items]
Revenues	$ 164,487	$ 162,320	$ 500,766	$ 492,326